Jackson, Grant Investment Advisers, Inc. Amgen Inc Transaction History

Jackson, Grant Investment Advisers, Inc.

$269 Million
Q2 2025

A detailed history of Jackson, Grant Investment Advisers, Inc. transactions in Amgen Inc stock. As of the latest transaction made, Jackson, Grant Investment Advisers, Inc. holds 2,378 shares of AMGN stock, worth $677,944. This represents 0.25% of its overall portfolio holdings.

Number of Shares

2,378

Previous 2,377 0.04%

Holding current value

$677,944

Previous $740,000 10.41%

% of portfolio

0.25%

Previous 0.29%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 17, 2025	BUY	$262.28 - $309.85 $262 - $309	1 Added 0.04%	2,378 $663,000
Q1 2025 May 06, 2025	BUY	$258.59 - $327.36 $258 - $327	1 Added 0.04%	2,377 $740,000
Q4 2024 Jan 27, 2025	BUY	$258.78 - $328.31 $258 - $328	1 Added 0.04%	2,376 $619,000
Q3 2024 Oct 17, 2024	BUY	$309.38 - $337.38 $309 - $337	1 Added 0.04%	2,375 $765,000
Q2 2024 Jul 16, 2024	BUY	$262.75 - $319.31 $33,632 - $40,871	128 Added 5.7%	2,374 $741,000
Q3 2023 Oct 13, 2023	SELL	$218.65 - $271.46 $4,810 - $5,972	-22 Reduced 0.97%	2,246 $603,000
Q1 2023 May 02, 2023	BUY	$225.79 - $275.2 $4,967 - $6,054	22 Added 0.98%	2,268 $548,000
Q1 2022 Apr 28, 2022	SELL	$219.27 - $242.57 $39,249 - $43,420	-179 Reduced 7.38%	2,246 $543,000
Q4 2020 Mar 03, 2021	SELL	$216.38 - $257.67 $32,673 - $38,908	-151 Reduced 5.86%	2,425 $558,000
Q3 2020 Nov 12, 2020	BUY	$234.65 - $260.95 $469 - $521	2 Added 0.08%	2,576 $655,000
Q2 2020 Aug 14, 2020	BUY	$197.81 - $242.74 $593 - $728	3 Added 0.12%	2,574 $607,000
Q1 2020 May 12, 2020	SELL	$182.24 - $241.7 $1,275 - $1,691	-7 Reduced 0.27%	2,571 $521,000
Q4 2019 Feb 05, 2020	BUY	$189.21 - $243.2 $378 - $486	2 Added 0.08%	2,578 $621,000
Q3 2019 Nov 20, 2019	BUY	$174.11 - $208.62 $348 - $417	2 Added 0.08%	2,576 $498,000
Q2 2019 Aug 13, 2019	BUY	$166.7 - $195.41 $500 - $586	3 Added 0.12%	2,574 $474,000
Q1 2019 May 07, 2019	SELL	$180.87 - $203.88 $723 - $815	-4 Reduced 0.16%	2,571 $488,000
Q4 2018 Jan 23, 2019	BUY	$178.4 - $208.25 $1,605 - $1,874	9 Added 0.35%	2,575 $501,000
Q3 2018 Nov 15, 2018	BUY	$185.29 - $208.89 $370 - $417	2 Added 0.08%	2,566 $532,000
Q2 2018 Aug 02, 2018	BUY	$166.05 - $186.51 $2,988 - $3,357	18 Added 0.71%	2,564 $473,000
Q1 2018 May 14, 2018	BUY	$169.43 - $198.0 $3,049 - $3,564	18 Added 0.71%	2,546 $434,000
Q4 2017 Feb 01, 2018	BUY	$168.79 - $188.59 $374,038 - $417,915	2,216 Added 710.26%	2,528 $440,000
Q3 2017 Nov 14, 2017	SELL	$167.29 - $191.0 $55,038 - $62,839	-329 Reduced 51.33%	312 $58,000
Q2 2017 Aug 10, 2017	BUY	N/A	641	641 $110,000

Others Institutions Holding AMGN

# of Institutions

3,274

Shares Held

427M

Call Options Held

7.33M

Put Options Held

7.38M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $153B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jackson, Grant Investment Advisers, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Jackson, Grant Investment Advisers, Inc. with notifications on news.

Account

Jackson, Grant Investment Advisers, Inc. Amgen Inc Transaction History